Incorrect username and/or password, please try again or click to reset.

Class 3 Medicines Recall: Lynparza capsule 50mg (olaparib)

2018-03-12 11:47:49 (2 year(s) ago)

Summary

AstraZeneca is recalling batch NG327 as the level of olaparib polymorphic form L exceeds the registered specification limit.

Read full MHRA article

Respond to this alert